Back to top
more

Select Medical (SEM)

(Delayed Data from NYSE)

$34.92 USD

34.92
645,318

+0.84 (2.46%)

Updated May 15, 2024 04:00 PM ET

After-Market: $34.92 0.00 (0.00%) 7:50 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value C Growth F Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 19% (48 out of 250)

Industry: Medical - HMOs

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Centene vs. Anthem: Which is a Better-Positioned Stock?

by Zacks Equity Research

Centene (CNC) and Anthem (ANTM) are poised to grow in the prospering health insurance industry. On comparative evaluation, we try to discover which stock is more profitable, based on the fundamentals.

Community Health (CYH) Up 64% YTD: More Growth Potential Left?

by Zacks Equity Research

Community Health Systems' (CYH) cost-control initiatives are likely to lower costs to a great extent and boost the bottom line.

Why Seasoned Investors are Retaining Select Medical (SEM) Stock

by Zacks Equity Research

Select Medical (SEM) is focused on making strategic acquisitions to boost its business through inorganic growth.

Select Medical (SEM) Q3 Earnings Beat, Hikes '21 EPS View

by Zacks Equity Research

Select Medical's (SEM) third-quarter results reflect solid revenues driven by strong segmental contributions, and an uptick in admissions and patient visits, partly offset by elevated costs.

Analysts Estimate Select Medical (SEM) to Report a Decline in Earnings: What to Look Out for

by Zacks Equity Research

Select Medical (SEM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Encompass Health (EHC) Rides on Solid Revenues, Expansion Plans

by Zacks Equity Research

Encompass Health (EHC) continues to gain, courtesy of sustained growth in revenues, sound expansion endeavors across the United States and a robust 2021 business outlook.

    Here's Why Select Medical (SEM) is a Strong Growth Stock

    by Zacks Equity Research

    The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

    Here's Why You Should Hold Onto Select Medical (SEM) Now

    by Zacks Equity Research

    Select Medical (SEM) is a long-term player on the back of its leadership position in acute care services.

    Centene vs. Anthem: Which is a Better-Positioned Stock?

    by Zacks Equity Research

    Centene (CNC) and Anthem (ANTM) are poised to grow in the thriving health insurance industry. On comparative evaluation, we try to discover which stock is more profitable, based on the fundamentals.

    7 Reasons Why Select Medical (SEM) Stock Looks Attractive

    by Zacks Equity Research

    Select Medical (SEM) looks a profitable investment bet on the back of its top-line growth, backed by a solid financial position as well as acquisitions and joint ventures.

    Is Select Medical (SEM) Stock Undervalued Right Now?

    by Zacks Equity Research

    Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

    Select Medical (SEM) Q2 Earnings Beat, Raises '21 EPS View

    by Zacks Equity Research

    Select Medical's (SEM) second-quarter results reflect strong top-line growth, higher admissions and increased patient visits, partly offset by elevated costs.

    Select Medical (SEM) Tops Q2 Earnings and Revenue Estimates

    by Zacks Equity Research

    Select Medical (SEM) delivered earnings and revenue surprises of 103.33% and 3.43%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

    Select Medical (SEM) Earnings Expected to Grow: Should You Buy?

    by Zacks Equity Research

    Select Medical (SEM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

    Encompass Health (EHC) Continues to Boost Presence in Florida

    by Zacks Equity Research

    Encompass Health (EHC) plans to construct an inpatient rehabilitation hospital in Florida in a bid to offer improved health outcomes across the state.

      Is Select Medical (SEM) a Great Value Stock Right Now?

      by Zacks Equity Research

      Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

      Is Select Medical Holdings (SEM) Stock Outpacing Its Medical Peers This Year?

      by Zacks Equity Research

      Is (SEM) Outperforming Other Medical Stocks This Year?

      Here's Why You Should Add Molina Healthcare (MOH) Stock Now

      by Zacks Equity Research

      Molina Healthcare (MOH) appears a lucrative investment option at the moment backed by strategic initiatives and healthy revenue stream.

      Anthem (ANTM) Buys MMM & Other Units From InnovaCare Health

      by Zacks Equity Research

      Anthem (ANTM) purchases subsidiaries of InnovaCare Health to facilitate better health outcomes across Puerto Rico.

      Encompass Health (EHC), Altru Forms JV to Serve North Dakota

      by Zacks Equity Research

      Encompass Health (EHC) inks JV with Altru for sharing responsibility of operating the latter's inpatient rehabilitation hospital and offer better health outcomes across North Dakota.

      What Makes Select Medical (SEM) a Strong Momentum Stock: Buy Now?

      by Zacks Equity Research

      Does Select Medical (SEM) have what it takes to be a top stock pick for momentum investors? Let's find out.

      Select Medical (SEM) Hits Fresh High: Is There Still Room to Run?

      by Zacks Equity Research

      Select Medical (SEM) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

      Centene (CNC) Offers Senior Notes Priced at $1.8 Billion

      by Zacks Equity Research

      Centene (CNC) exhibits prudence in issuing notes to procure funds for executing the transaction of its Magellan Health acquisition.

      Is Select Medical (SEM) Stock Undervalued Right Now?

      by Zacks Equity Research

      Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

      Select Medical (SEM) Is Attractively Priced Despite Fast-paced Momentum

      by Zacks Equity Research

      If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Select Medical (SEM) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.